Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
122.10
+4.70 (4.00%)
Jul 31, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
32,32124,53816,49414,01410,00814,112
Market Cap Growth
5.29%48.77%17.70%40.02%-29.08%-9.11%
Enterprise Value
30,66423,57815,21312,6589,44313,028
Last Close Price
122.1092.7062.3152.9441.7058.80
Forward PE
64.1835.5135.5135.5135.51-
PS Ratio
19.7130.2830.9536.2633.1174.13
PB Ratio
18.7922.7113.178.5212.7111.26
P/TBV Ratio
19.0623.3713.708.9614.9813.07
P/OCF Ratio
40.57-431.73---
EV/Sales Ratio
18.7029.0928.5432.7631.2468.44
Debt / Equity Ratio
0.471.050.830.540.700.18
Net Debt / Equity Ratio
-0.96-0.83-0.92-0.83-0.63-0.78
Net Debt / EBITDA Ratio
-3.184.476.653.821.032.11
Net Debt / FCF Ratio
-2.574.2720.094.601.091.86
Asset Turnover
0.500.270.180.170.180.10
Inventory Turnover
0.600.460.260.300.370.19
Quick Ratio
2.261.541.712.081.573.35
Current Ratio
2.501.711.882.221.773.69
Return on Equity (ROE)
38.00%-14.16%-10.37%-24.27%-47.59%-31.38%
Return on Assets (ROA)
9.26%-5.08%-4.60%-10.91%-19.70%-17.02%
Return on Capital Employed (ROCE)
20.70%-15.80%-13.30%-22.70%-57.30%-37.10%
Earnings Yield
1.70%-0.66%-0.84%-1.99%-4.57%-3.20%
FCF Yield
2.00%-0.86%-0.35%-2.11%-4.59%-3.72%
Buyback Yield / Dilution
-1.16%0.85%-3.71%-6.74%0.19%-2.20%